|Título||Cross-cultural adaptation and validation to Brazilian Portuguese of two measuring adherence instruments for patients with type 1 diabetes
Teló, Gabriela Heiden
Souza, Martina Schaan de
Schaan, Beatriz D'Agord
|Abstract||Background: The purpose of this study was to carry out a cross-cultural adaptation to Brazilian Portuguese, validation, and comparison of two questionnaires to measure adherence in patients with type 1 diabetes. There are no validated instruments to measure treatment adherence in Brazilian patients with type 1 diabetes. Methods: Type 1 diabetes outpatients of a tertiary hospital in Southern Brazil were recruited to examine psychometric properties of the Diabetes Self-Management Profile (DSMP) and Self-Care Inventory-revised (SCI-R) adapted to Brazilian Portuguese. Analyses assessed the reliability and validity according to its associations with glycated hemoglobin (A1C). Seventy-five patients [age: 34.9 ± 13.7 years; A1C: 9.2 ± 2% (75 mmol/mol); diabetes duration: 18.1 ± 11.8 years] were evaluated. Results: The translated versions of the instruments showed adequate internal consistency (DSMP Cronbach’s α =0.76; SCI-R Cronbach’s α =0.71). A positive correlation was found between all the items and total scores, except for item 12 in DSMP and item 13 in SCI-R, and for this reason, these items were excluded from the translated versions. In predictive validity analysis, A1C correlated significantly with the DSMP total (r = −0.46) and with the SCI-R total (r = −0.44). Conclusions: The Brazilian Portuguese versions of DSMP and SCI-R yielded a reliable and valid tool to measure adherence treatment for patients with type 1 diabetes, with a significant correlation between total scores and A1C.
|Contido em||Diabetology & metabolic syndrome. São Paulo. Vol. 6 (Dec. 2014), 6p.
Complacência (medida de distensibilidade)
Diabetes mellitus tipo 1
[en] Type 1 diabetes
|Tipo||Artigo de periódico
|000953536.pdf (167.6Kb)||Texto completo (inglês)||Adobe PDF||Visualizar/abrir|
Este item está licenciado na Creative Commons License